Geneva Homologous Recombination Deficiency Test Is Predictive of Survival Benefit From Olaparib and Bevacizumab Maintenance in Ovarian Cancer.

Saved in:
Bibliographic Details
Title: Geneva Homologous Recombination Deficiency Test Is Predictive of Survival Benefit From Olaparib and Bevacizumab Maintenance in Ovarian Cancer.
Authors: Christinat Y; Department of Clinical Pathology, Hôpitaux Universitaires de Genève, Geneva, Switzerland., Labidi-Galy I; Department of Oncology, Hôpitaux Universitaires de Genève, Geneva, Switzerland.; Faculty of Medicine, Université de Genève, Geneva, Switzerland.; SAKK, Bern, Switzerland., Ho L; Department of Clinical Pathology, Hôpitaux Universitaires de Genève, Geneva, Switzerland., Clément S; Faculty of Medicine, Université de Genève, Geneva, Switzerland., Genestie C; Gustave Roussy, Paris, France., Sehouli J; Charité-Universitätsmedizin Berlin (CVK) and AGO, Berlin, Germany., Cinieri S; U.O.C. Oncologia Medica-Ospedale Senatore Antonio Perrino, Brindisi, Italy.; MITO, Brindisi, Italy., Gonzalez-Martin A; Medical Oncology Department, Clinica Universidad de Navarra, Madrid, Spain.; GEICO, Madrid, Spain., Kolovetsiou-Kreiner V; Department of Obstetrics and Gynecology, Division of Gynecology, Medical University of Graz, Graz, Austria.; AGO Austria, Graz, Austria., Fujiwara K; Saitama Medical University International Medical Center and GOTIC, Saitama, Japan., Von Gorp T; Belgium and Luxembourg Gynaecological Oncology Group, University Hospitals Leuven and Leuven Cancer Institute, Leuven, Belgium.; BGOG, Leuven, Belgium., Tognon G; Spedali Civili di Brescia and MaNGO, Brescia, Italy., Hietanen S; Department of Obstetrics and Gynecology, Turku University Hospital, Turku, Finland.; NSGO-CTU, Copenhagen, Denmark., Heinzelmann-Schwarz V; SAKK, Bern, Switzerland.; Women University Hospital, University Hospital Basel, Basel, Switzerland., Ray-Coquard I; Centre Leon Bérard and University Claude Bernard Lyon I and GINECO, Lyon, France.; ARCAGY-GINECO, Paris, France., Pujade-Lauraine E; ARCAGY-GINECO, Paris, France., McKee TA; Department of Clinical Pathology, Hôpitaux Universitaires de Genève, Geneva, Switzerland.; Faculty of Medicine, Université de Genève, Geneva, Switzerland.
Source: JCO precision oncology [JCO Precis Oncol] 2025 Jul; Vol. 9, pp. e2400825. Date of Electronic Publication: 2025 Jul 02.
Publication Type: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2473-4284
DOI:10.1200/PO-24-00825